Pharmacokinetics of guaifenesin, pseudoephedrine and hydrocodone in a combination oral liquid formulation, administered as single and multiple doses in healthy Chinese volunteers, and comparison with data for individual compounds formulated as Antuss®

References

• Assimos DG, Langenstroer P, Leinbach RF, et al. (1999). Guaifenesin- and ephedrine-induced stones. J Endourol. 13:665–7
   PubMed Web of Science ®Google Scholar
• Azzaro AJ, van den Berg CM, Ziemniak J, et al. (2007). Evaluation of the potential for pharmacodynamic and pharmacokinetic drug interactions between selegiline transdermal system and two sympathomimetic agents (pseudoephedrine and phenylpropanolamine) in healthy volunteers. J Clin Pharmacol 47:978–90
   PubMed Web of Science ®Google Scholar
• Clinical Research Coordination Group of Guaifenesin Compound Pseudoephedrine Hydrochloride Oral Solution, Lu Q. (2010). [A prospective multicenter randomized controlled clinical study on the efficacy and safety of Guaifenesin compound pseudoephedrine hydrochloride oral solution]. Zhonghua Er Ke Za Zhi 48:204–7
   PubMedGoogle Scholar
• Cone EJ, Heltsley R, Black DL, et al. (2013). Prescription opioids. II. Metabolism and excretion patterns of hydrocodone in urine following controlled single-dose administration. J Anal Toxicol 37:486–94
   PubMed Web of Science ®Google Scholar
• Davis SS, Eccles R. (2004). Nasal congestion: mechanisms, measurement and medications. Core information for the clinician. Clin Otolaryngol Allied Sci 29:659–66
   PubMed Web of Science ®Google Scholar
• Delbeke FT, Debackere M. (1991). The influence of diuretics on the excretion and metabolism of doping agents: Part VI. Pseudoephedrine. Biopharm Drug Dispos 12:37–48
   PubMed Web of Science ®Google Scholar
• Devarakonda K, Kostenbader K, Giuliani MJ, et al. (2015). Comparison of single-dose and multiple-dose pharmacokinetics between two formulations of hydrocodone bitartrate/acetaminophen: immediate-release versus biphasic immediate-release/extended release. J Pain Res 98:607–18
   Web of Science ®Google Scholar
• Dicpinigaitis PV, Eccles R, Blaiss MS, et al. (2015). Impact of cough and common cold on productivity, absenteeism, and daily life in the United States: ACHOO Survey. Curr Med Res Opin 31:1519–25
   PubMed Web of Science ®Google Scholar
• Dicpinigaitis PV, Gayle YE. (2003). Effect of guaifenesin on cough reflex sensitivity. Chest 124:2178–81
   PubMed Web of Science ®Google Scholar
• Eccles R, Jawad MS, Jawad SS, et al. (2005). Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold. Am J Rhinol 19:25–31
   PubMedGoogle Scholar
• Eccles R, Voelker M. (2013). Analgesic and decongestant efficacy of the combination of aspirin with pseudoephedrine in patients with symptoms of upper respiratory tract infection. Clin Pharmacol Drug Dev 3:118–25
   PubMed Web of Science ®Google Scholar
• Graziani M, Nisticò R. (2016). Gender difference in prescription opioid abuse: a focus on oxycodone and hydrocodone. Pharmacol Res 108:31–8
   PubMed Web of Science ®Google Scholar
• Homsi J, Walsh D, Nelson KA, et al. (2002). A phase II study of hydrocodone for cough in advanced cancer. Am J Hosp Palliat Care 19:49–56
   PubMedGoogle Scholar
• Howard DR, Haribhakti R, Kittner B, et al. (2005). Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults. Curr Med Res Opin 21:769–76
   PubMed Web of Science ®Google Scholar
• Kagan L, Lavy E, Hoffman A. (2009). Effect of mode of administration on guaifenesin pharmacokinetics and expectorant action in the rat model. Pulm Pharmacol Therap 6:1–6
   Google Scholar
• Kale P. (2014). Pharmacokinetics and bioavailability of single dose ibuprofen and pseudoephedrine alone or in combination: a randomized three-period, cross-over trial in healthy Indian volunteers. Front Pharmacol 95:98
   PubMed Web of Science ®Google Scholar
• Oliver SD, Rees TP, Daniel RJE. (1996). The pharmacokinetics and clinical activity of a soluble combination of ibuprofen and pseudoephedrine. Eur J Clin Res 8:269–80
   Google Scholar
• Sperber SJ, Sorrentino JV, Riker DK, et al. (1989). Evaluation of an alpha agonist alone and in combination with a non-steroidal anti-inflammatory agent in the treatment of experimental rhinovirus colds. Bull NY Acad Med 65:145–60
   PubMedGoogle Scholar
• Stillings M, Little S, Sykes J. (2003). Common cold and influenza symptom management: the use of pharmacokinetic considerations to predict the efficacy of a twice-daily treatment for colds and flu. Curr Med Res Opin 19:791–9
   PubMed Web of Science ®Google Scholar
• Thompson GA, Solomon G, Albrecht HH, et al. (2016). Guaifenesin pharmacokinetics following single-dose oral administration in children aged 2 to 17 years. J Clin Pharmacol 56:894–901
   PubMed Web of Science ®Google Scholar
• Vernacchio L, Kelly JP, Kaufman DW, et al. (2008). Pseudoephedrine use among US children, 1999–2006: results from the Slone survey. Pediatrics 122:1299–304
   PubMed Web of Science ®Google Scholar
• Vilson L, Jr Owen JS. (2013). Pharmacokinetic studies in healthy subjects for the development of an extended-release tablet formulation of guaifenesin: a 505(b)(2) new drug application approval. Clin Pharmacol Drug Dev 2:25–32
   PubMed Web of Science ®Google Scholar
• Wen J, Zhang H, Xia C, et al. (2010). A sensitive liquid chromatography-electrospray ionization-mass spectrometry method for the simultaneous determination of pentoxyverine citrate and guaifenesin in human plasma-application to pharmacokinetic and bioequivalence studies. Biomed Chromatogr 24:351–7
   PubMed Web of Science ®Google Scholar
• World Medical Association. (2008). Declaration of Helsinki (Version, 2008). [Internet]. Available from: http://www.wma.net/en/20activities/10ethics/10helsinki/
   Google Scholar
• Zhang R, Wang B, Wei C, et al. (2009). Determination and pharmacokinetic study of hydrocodone in human plasma by liquid chromatography coupled with tandem mass spectrometry. Artif Cells Blood Substit Immobil Biotechnol 37:203–7
   PubMed Web of Science ®Google Scholar